IDURSULFASE Side Effects

7022468-7 | Idiopathic Thrombocytopenic Purpura
on Sep 24, 2010 Male patient from TURKEY , 20 years of age, was diagnosed with mucopolysaccharidosis ii and was treated with Idursulfase (View Usage). Patient experienced the following unwanted or unexpected effects: idiopathic thrombocytopenic purpura. Idursulfase dosage: .5 Mg/kg, 1x/week.

6899457-6 | Eyelid Oedema, Infusion Related Reaction, Respiratory Disorder, Urticaria
Patient was taking Idursulfase (View Usage). Patient had the following side effects: eyelid oedema, infusion related reaction, respiratory disorder, urticaria on Jul 29, 2010 from JAPAN Additional patient health information: Male patient , weighting 61.73 lb, was diagnosed with mucopolysaccharidosis ii and. Idursulfase dosage: . During the same period patient was treated with LORATADINE (10 Mg, 1x/day:qd) (View Loratadine Review and Loratadine Label ), HYDROXYZINE PAMOATE (25 Mg, One Dose) (View Hydroxyzine Pamoate Review and Hydroxyzine Pamoate Label ), METHYLPREDNISOLONE SODIUM SUCCINATE (20 Mg, One Dose) (View Methylprednisolone Sodium Succinate Review and Methylprednisolone Sodium Succinate Label ), HYDROCORTISONE SODIUM SUCCINATE (300 Mg, One Dose) (View Hydrocortisone Sodium Succinate Review and Hydrocortisone Sodium Succinate Label ).

6818969-4 | Epilepsy
Adverse event was reported on Jun 25, 2010 by a Male patient taking Idursulfase (View Usage) (Dosage: 11.2 Mg, 1x/week) was diagnosed with mucopolysaccharidosis ii and. Location: UNITED STATES , weighting 50.71 lb, After Idursulfase was administered, patient had the following side effects: epilepsy (What is epilepsy?). During the same period patient was treated with CHLORPHENIRAMINE MALEATE (.5 Ml, Unk) (View Chlorpheniramine Maleate Review and Chlorpheniramine Maleate Label ).

6743366-X | Infusion Related Reaction, Respiratory Distress
on May 20, 2010 Male patient from BRAZIL , weighting 33.07 lb, was diagnosed with mucopolysaccharidosis ii, upper respiratory tract infection and was treated with Idursulfase (View Usage). Patient experienced the following unwanted or unexpected effects: infusion related reaction, respiratory distress. Idursulfase dosage: Unk, 1x/week. During the same period patient was treated with PENICILLIN /00000901/ (Unk, Unk) (View Penicillin /00000901/ Review and Penicillin /00000901/ Label ).


5406182-7 | Blood Immunoglobulin G Increased, Blood Potassium Decreased, Blood Sodium Decreased, Decreased Appetite, Diarrhoea, Dysgeusia, Fatigue, Iron Deficiency Anaemia, Pharyngitis Streptococcal
on Jul 18, 2007 Male patient from UNITED STATES , child 8 years of age, weighting 50.04 lb, was diagnosed with mucopolysaccharidosis ii and was treated with Idursulfase (View Usage). Patient had the following side effects: blood immunoglobulin g increased, blood potassium decreased, blood sodium decreased, decreased appetite, diarrhoea, dysgeusia, fatigue, iron deficiency anaemia, pharyngitis streptococcal. Idursulfase dosage: (11.5 Mg, 1 In 1 Wk), Intravenous Drip. During the same period patient was treated with NASONEX (View Nasonex Review and Nasonex Label ), SINGULAIR (View Singulair Review and Singulair Label ). Patient was hospitalized.

5371757-0 | Appendicitis, Peritonitis
Patient was taking Idursulfase (View Usage). After Idursulfase was administered, patient had the following side effects: appendicitis (What is appendicitis?), peritonitis on Jun 07, 2007 from SPAIN Additional patient health information: Male patient , 18 years of age, weighting 92.59 lb, was diagnosed with mucopolysaccharidosis ii and. Idursulfase dosage: 21 Mg, 1 In 1 Wk, Intraveous Drip. During the same period patient was treated with ENALAPRIL (ENALAPRIL ) (View Enalapril (enalapril ) Review and Enalapril (enalapril ) Label ). Patient was hospitalized.